SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-357124
Filing Date
2013-09-04
Accepted
2013-09-04 17:03:06
Documents
3
Period of Report
2013-09-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d593084d8k.htm 8-K 16392
2 EX-99.1 d593084dex991.htm EX-99.1 7410
3 GRAPHIC g593084g50c56.jpg GRAPHIC 11519
  Complete submission text file 0001193125-13-357124.txt   41239
Mailing Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 131078494
SIC: 2835 In Vitro & In Vivo Diagnostic Substances